Thyroid disease

Preconception body mass index and maternal thyroid function: a longitudinal observational study

Eur Thyroid JPublished Prospective cohort study

Authors' conclusion

Higher p-BMI is associated with a persistently less favorable maternal thyroid hormone profile throughout pregnancy. Low FT4 concentrations during early pregnancy showed the strongest association with obstetric risk, supporting further investigation into early thyroid assessment in higher-risk populations.

Study context

Population
Pregnant women stratified by preconception BMI; thyroid function at ≤13 gestational weeks and two later time points
Participants
1,107 women
Exposure
Overweight and obese vs normal-weight preconception BMI
Outcome
Maternal thyroid function (TSH and FT4) longitudinally over pregnancy
Methodological detailslongitudinal, observational
  • Longitudinal
  • Observational

Main finding

As reported in the abstract

early pregnancy and across gestation
  • At early pregnancy, overweight (OW) and obese (OB) had lower free thyroxine (FT4) and higher TSH than normal weight (NW)
  • Across gestation, FT4 declined and TSH increased in all BMI categories, with persistently lower FT4 and higher TSH with higher BMI
  • No significant preconception body mass index (p-BMI) × gestational period interaction

Observational data: associations, not effects.

Further findings

Composite adverse obstetric outcome by first-trimester low FT4 (exploratory)

OR (95% CI)P value
Low FT4Independently associated · exploratory analysis2.04 (1.32–3.11)P = 0.001

Composite adverse obstetric outcome by first-trimester elevated TSH (exploratory)

OR (95% CI)P value
Elevated TSHExploratory analysis1.71 (1.04–2.77)P = 0.03

Original publication

Preconception body mass index and maternal thyroid function: a longitudinal observational study. Eur Thyroid J. Published 20 May 2026. doi:10.1530/etj-26-0052

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.